Lactobacillus casei Alleviated the Abnormal Increase of Cholestasis-Related Liver Indices During Tuberculosis Treatment: A Post Hoc Analysis of Randomized Controlled Trial.

Ke XiongJing CaiPeiying LiuJinyu WangShanliang ZhaoLei XuYang YangJiahong LiuAiguo Ma

Published in: Molecular nutrition & food research (2021)

L. casei supplementation is beneficial for suppressing abnormally elevated cholestasis-related liver indices during tuberculosis treatment, which may be related to its modification on blood lipopolysaccharide, intestinal barrier function, and gut microbiota.

Keyphrases

randomized controlled trial
mycobacterium tuberculosis
drug induced
study protocol
clinical trial
pulmonary tuberculosis
hiv aids
signaling pathway
systematic review
combination therapy